| Dr Samantha Bennett, DPT | |
|
130 Admiral Cochrane Dr, Suite 101, Annapolis, MD 21401-7368 | |
| (410) 266-1500 | |
| (410) 266-1369 |
| Full Name | Dr Samantha Bennett |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 130 Admiral Cochrane Dr, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366875551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 24621 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samantha Bennett, DPT 130 Admiral Cochrane Dr, Suite 101, Annapolis, MD 21401-7368 Ph: (410) 266-1500 | Dr Samantha Bennett, DPT 130 Admiral Cochrane Dr, Suite 101, Annapolis, MD 21401-7368 Ph: (410) 266-1500 |
News Archive
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Although black and Hispanic veterans with chronic kidney disease are more likely than white patients to see a kidney specialist- a nephrologist- they are more likely to suffer disease progression from early stage to advanced kidney disease, reports a study published this month in the Journal of the American Society of Nephrology from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers from the Université de Montréal School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre in collaboration with researchers at Boston University School of Medicine.
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
› Verified 5 days ago
Chesapeake Lymphedema And Physical Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3212 Chrisland Dr, Annapolis, MD 21403 Phone: 443-510-2932 | |
Hsu Huei Thigpen, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 205 Ridgely Ave, Annapolis, MD 21401 Phone: 443-433-0468 | |
Dr. Katherine Ann Noblitt, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 127 Lubrano Dr Ste 203, Annapolis, MD 21401 Phone: 570-662-2317 | |
Dr. Craig Trueblood, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Parkway, Belcher Pavillion, Suite 404, Annapolis, MD 21401 Phone: 443-481-1140 | |
Kristen Czerwinski, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2000 Medical Pkwy Ste 404, Annapolis, MD 21401 Phone: 443-481-1140 | |
Privia Medical Group, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1834 George Ave, Annapolis, MD 21401 Phone: 443-441-0631 | |
Mr. Jeremy Wayne Cugle, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2448 Holly Ave, Suite 200, Annapolis, MD 21401 Phone: 410-295-4941 Fax: 410-295-5207 |